The markets plummeted to close sharply lower with the Dow crashing 394 points to 18,085 over concerns that interest rates would soon rise. Nasdaq collapsed 133 points to 5,125.
On the upside
Auris Medical (Nasdaq: EARS) reached the midpoint for enrollment in the HEALOS Phase 3 clinical trial of AM-111 to sudden deafness.
Piper Jaffray initiated coverage of Aptevo Therapeutics (Nasdaq: APVO) with an Overweight rating.
Shares of Teekay LNG Partners (NYSE: TPG) extended its gains.
On the downside
Violin Memory (NYSE: VMEM) reported a loss for the second quarter as revenue plunged.
Investors locked in profits on Momo (Nasdaq: MOMO).
Falling gold prices weighed down shares of Coeur Mining (NYSE: CDE).
In the broad market, declining issues outpaced advancers by a margin of nearly 19 to 1 on the NYSE and by 6 to 1 on Nasdaq. The broader S&P 500 plummeted 53 points to 2,127. Bitcoin slipped to $621.
